E. Ohman J:or Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q3 | $2.6M | Hold |
|
|||||
2025
Q2 | $1.86M | Sell |
|
|||||
2025
Q1 | $1.57M | Sell |
|
|||||
2024
Q4 | $1.44M | Buy |
|
|||||
2024
Q3 | $1.49M | Buy |
|
|||||
2023
Q3 | – | Sell |
|
|||||
2023
Q2 | $380K | Hold |
|
|||||
2023
Q1 | $401K | Buy |
|
|||||
2022
Q1 | – | Sell |
|
|||||
2021
Q4 | $1.09M | Buy |
|
|||||
2021
Q2 | – | Sell |
|
|||||
2021
Q1 | $353K | Hold |
|
|||||
2020
Q4 | $325K | Hold |
|
|||||
2020
Q3 | $364K | Buy |
|
|||||
2020
Q2 | – | Sell |
|
|||||
2020
Q1 | $250K | Sell |
|
|||||
2019
Q4 | $369K | Buy |
|
|||||
2018
Q2 | – | Sell |
|
|||||
2018
Q1 | $262K | Hold |
|
|||||
2017
Q4 | $280K | Buy |
|
|||||
2016
Q4 | – | Sell |
|
|||||
2016
Q3 | $108K | Hold |
|
|||||
2016
Q2 | $88.8K | Hold |
|
|||||
2016
Q1 | $100K | Hold |
|
|||||
2015
Q4 | $151K | Hold |
|
|||||
2015
Q3 | $129K | Hold |
|
|||||
2015
Q2 | $192K | Buy |
|